Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13D/A Feb 15, 2024
4 Feb 15, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
SC 13G Feb 14, 2024 SC 13G
424B5 Feb 14, 2024 424B5
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G Feb 14, 2024 SC 13G
8-K Feb 14, 2024 8-K
SC 13G/A Feb 13, 2024 JHG PLC & JHBIF >5%
424B5 Feb 13, 2024 424B5
8-K Feb 12, 2024 8-K
4 Jan 19, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jan 19, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jan 19, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jan 19, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Dec 8, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
10-Q Nov 14, 2023 10-Q
8-K Nov 14, 2023 8-K
4 Oct 5, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
3 Oct 5, 2023 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
8-K Oct 3, 2023 8-K
SC 13G Aug 18, 2023 JHG PLC OWNS 5.1% LARIMAR
8-K Aug 14, 2023 8-K
10-Q Aug 10, 2023 10-Q
8-K Aug 10, 2023 8-K
8-K Jul 25, 2023 8-K
← Newer Page 6 of 28 · 693 filings Older →